Form 13-F position report

NEUBASE THERAPEUTICS INC

Reported by GEODE CAPITAL MANAGEMENT LLC

NBSE CUSIP 64132K102 Manager CIK 0001214717

Reported 234,571 shares, down 9,413 (3.9%) from the prior quarter.

Reported value -46.3%; share count -3.9% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 234,571 Quarter-end amount reported
Reported value $246,000 Fair value at quarter end
Consecutive quarters held 12 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 865000
2021-12-31 685000
2022-03-31 458000
2022-06-30 246000
2022-09-30 92000
2022-12-31 44000
2023-03-31 43285
2023-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

8 quarters
Quarterly reported position history for NEUBASE THERAPEUTICS INC held by GEODE CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2023 Reduced 0 -233,973 (-100.0%) 0 $0 2023-08-11
Q1 2023 Unchanged 233,973 0 (0.0%) < 0.01% $43,285 2023-05-15
Q4 2022 Reduced 233,973 -598 (-0.3%) < 0.01% $44,000 2023-02-13
Q3 2022 Unchanged 234,571 0 (0.0%) < 0.01% $92,000 2022-11-14
Q2 2022 Reduced 234,571 -9,413 (-3.9%) < 0.01% $246,000 2022-08-12
Q1 2022 Unchanged 243,984 0 (0.0%) < 0.01% $458,000 2022-05-13
Q4 2021 Added 243,984 +4,165 (1.7%) < 0.01% $685,000 2022-02-11
Q3 2021 Added 239,819 +5,963 (2.5%) < 0.01% $865,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

51 managers reported NEUBASE THERAPEUTICS INC for Q2 2022.

Managers reporting NEUBASE THERAPEUTICS INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
GREENLIGHT CAPITAL INC Unchanged 2,727,027 0 0.22% $2,863,000 12 qtrs
Point72 Asset Management L P Unchanged 1,250,000 0 < 0.01% $1,313,000 5 qtrs
VANGUARD GROUP INC Unchanged 1,059,054 0 < 0.01% $1,112,000 12 qtrs
AIGH Capital Management LLC Unchanged 1,027,585 0 0.28% $1,079,000 3 qtrs
Decheng Capital Management III Cayman LLC Unchanged 1,000,000 0 0.4% $1,050,000 2 qtrs
CARNEGIE MELLON UNIVERSITY Unchanged 939,412 0 0.5% $986,000 3 qtrs
Sio Capital Management LLC Unchanged 906,445 0 0.36% $952,000 9 qtrs
Polar Asset Management Partners Inc Unchanged 634,618 0 < 0.01% $666,000 6 qtrs
Kestra Advisory Services LLC New 510,678 +510,678 < 0.01% $536,000 1 qtr
JACOB ASSET MANAGEMENT OF NEW YORK LLC Added 470,524 +44,100 0.5% $494,000 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 12, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
234,571
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.